Osaic Holdings’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.4K | Buy |
4,305
+2,930
| +213% | +$9.82K | ﹤0.01% | 5537 |
|
2025
Q1 | $4.11K | Sell |
1,375
-2,925
| -68% | -$8.75K | ﹤0.01% | 6176 |
|
2024
Q4 | $14.4K | Sell |
4,300
-533
| -11% | -$1.79K | ﹤0.01% | 5514 |
|
2024
Q3 | $16.2K | Buy |
4,833
+1,033
| +27% | +$3.46K | ﹤0.01% | 5450 |
|
2024
Q2 | $12.6K | Sell |
3,800
-3,526
| -48% | -$11.7K | ﹤0.01% | 5579 |
|
2024
Q1 | $29.6K | Hold |
7,326
| – | – | ﹤0.01% | 5081 |
|
2023
Q4 | $22.3K | Sell |
7,326
-1,825
| -20% | -$5.57K | ﹤0.01% | 5426 |
|
2023
Q3 | $27.5K | Buy |
9,151
+1,997
| +28% | +$5.99K | ﹤0.01% | 5366 |
|
2023
Q2 | $26.8K | Buy |
7,154
+3,453
| +93% | +$12.9K | ﹤0.01% | 5361 |
|
2023
Q1 | $12.4K | Sell |
3,701
-70
| -2% | -$234 | ﹤0.01% | 5820 |
|
2022
Q4 | $19K | Sell |
3,771
-421
| -10% | -$2.12K | ﹤0.01% | 5581 |
|
2022
Q3 | $24K | Hold |
4,192
| – | – | ﹤0.01% | 5417 |
|
2022
Q2 | $29K | Buy |
4,192
+122
| +3% | +$844 | ﹤0.01% | 5343 |
|
2022
Q1 | $28K | Buy |
4,070
+1,794
| +79% | +$12.3K | ﹤0.01% | 5446 |
|
2021
Q4 | $20K | Buy |
2,276
+1,950
| +598% | +$17.1K | ﹤0.01% | 5752 |
|
2021
Q3 | $11K | Buy |
326
+150
| +85% | +$5.06K | ﹤0.01% | 6114 |
|
2021
Q2 | $4K | Buy |
+176
| New | +$4K | ﹤0.01% | 6417 |
|